» Articles » PMID: 33468488

Adaptive Processes Change As Multiple Functions Evolve

Overview
Specialty Pharmacology
Date 2021 Jan 20
PMID 33468488
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Epistasis influences the gene-environment interactions that shape bacterial fitness through antibiotic exposure, which can ultimately affect the availability of certain resistance phenotypes to bacteria. The substitutions present within confer both cephalosporin and β-lactamase inhibitor resistance. We wanted to compare the evolution of with that of another variant, , which differs in that contains only substitutions that contribute to cephalosporin resistance. Differences between the landscapes and epistatic interactions of these TEM variants are important for understanding their separate evolutionary responses to antibiotics. We hypothesized the substitutions within would result in more epistatic interactions than for As expected, we found more epistatic interactions between the substitutions present in than in Our results suggest that selection from many cephalosporins is required to achieve the full potential resistance to cephalosporins but that a single β-lactam and inhibitor combination will drive evolution of the full potential resistance phenotype. Surprisingly, we also found significantly positive increases in growth rates as antibiotic concentration increased for some of the strains expressing precursor genotypes but not the variants. This result further suggests that additive interactions more effectively optimize phenotypes than epistatic interactions, which means that exposure to numerous cephalosporins actually increases the ability of a TEM enzyme to confer resistance to any single cephalosporin.

Citing Articles

Evolutionary druggability for low-dimensional fitness landscapes toward new metrics for antimicrobial applications.

Guerrero R, Dorji T, Harris R, Shoulders M, Ogbunugafor C Elife. 2024; 12.

PMID: 38833384 PMC: 11149929. DOI: 10.7554/eLife.88480.


Evolutionary druggability: leveraging low-dimensional fitness landscapes towards new metrics for antimicrobial applications.

Guerrero R, Dorji T, Harris R, Shoulders M, Ogbunugafor C bioRxiv. 2023; .

PMID: 37066376 PMC: 10104179. DOI: 10.1101/2023.04.08.536116.


Epistasis decreases with increasing antibiotic pressure but not temperature.

Ghenu A, Amado A, Gordo I, Bank C Philos Trans R Soc Lond B Biol Sci. 2023; 378(1877):20220058.

PMID: 37004727 PMC: 10067269. DOI: 10.1098/rstb.2022.0058.


Allogenous Selection of Mutational Collateral Resistance: Old Drugs Select for New Resistance Within Antibiotic Families.

Baquero F, Martinez J, Novais A, Rodriguez-Beltran J, Martinez-Garcia L, Coque T Front Microbiol. 2021; 12:757833.

PMID: 34745065 PMC: 8569428. DOI: 10.3389/fmicb.2021.757833.

References
1.
Chanal C, Bonnet R, De Champs C, Sirot D, Labia R, Sirot J . Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital. Antimicrob Agents Chemother. 2000; 44(7):1930-5. PMC: 89988. DOI: 10.1128/AAC.44.7.1930-1935.2000. View

2.
Sirot D, Recule C, Chaibi E, Bret L, Croize J, Labia R . A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 1997; 41(6):1322-5. PMC: 163908. DOI: 10.1128/AAC.41.6.1322. View

3.
de Visser J, Krug J . Empirical fitness landscapes and the predictability of evolution. Nat Rev Genet. 2014; 15(7):480-90. DOI: 10.1038/nrg3744. View

4.
Weinreich D, Delaney N, DePristo M, Hartl D . Darwinian evolution can follow only very few mutational paths to fitter proteins. Science. 2006; 312(5770):111-4. DOI: 10.1126/science.1123539. View

5.
Aminov R . A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 2011; 1:134. PMC: 3109405. DOI: 10.3389/fmicb.2010.00134. View